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ABSTRACT
Objective: This study aimed to further investigate the antiplatelet and antithrombotic activities of Trigonella foenum-graceum (TFG) in vivo.
Methods: Male mice were divided into two experimental groups (bleeding duration and survival rate). The study groups comprised vehicle controls 
(administered carboxymethyl cellulose [CMC]), negative controls (administered CMC), positive controls (administered aspirin), and experimental 
treatment groups (administered TFG extract at three doses). Bleeding duration was assessed by excising the tail vein. Survival rate was determined 
by inducing thrombosis through intravenous collagen/epinephrine administration.
Results: In mice treated with TFG extract for 7 days, bleeding duration was significantly increased compared with that in controls (p<0.05). Moreover, 
mice treated with TFG showed increased survival rates compared with negative controls.
Conclusion: TFG extract showed antithrombotic activity in mice by significantly increasing bleeding duration and survival rate.
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INTRODUCTION
Cardiovascular diseases, including thrombosis, stroke, ischemic heart 
disease, and coronary heart disease, are a leading cause of mortality. 
In particular, thrombotic diseases represent a major cardiovascular 
complication affecting many patients [1]. Thrombi formed in the circulatory 
system due to the disruption of homeostasis can cause vascular blockage, 
atherothrombotic diseases, and myocardial or cerebral necrosis, which can 
lead to death [2]. Platelets are essential to maintain the vascular integrity 
and to stop bleeding through blood clot formation, but they have also 
been implicated to play a role in the pathological progression of arterial 
vascular thrombosis through adhesion to injured vessels, aggregation to 
form plugs and acceleration of coagulation cascades [3]. Inhibiting platelet 
aggregation is a strategy for preventing cardiovascular diseases.
Trigonella foenum-graceum (TFG) or fenugreek is widely distributed 
in Indonesia and is consumed as a lactagogue by breastfeeding 
mothers. A previous study has shown that fenugreek leaves possess 
antithrombotic activity [4]. Fenugreek seeds contain coumarin – a 
flavonoid with in vitro antithrombotic activity [5,6].
In this study, we aimed to further investigate the antiplatelet and 
antithrombotic activities of TFG in vivo. The antithrombotic activity of 




Plants simplisia and aqueous extract were obtained from the Indonesian 
Spice and Medicinal Crops Research Institute, Bogor. Plant materials 
were deposited in the Center for Plant Conservation Botanic Gardens 
(No. B-1691/IPH.3/KS/VI/2017).
Chemicals
Ethyl alcohol (70% v/v), Aqua Dest distilled water, saline solution, 
ether, aspirin, and collagen were obtained from Sigma-Aldrich 
(Japan Corporation). CMC was purchased from Brataco (Indonesia). 
Epinephrine was obtained from Sigma-Aldrich (Singapore).
Experimental animals
Male DDY mice (Mus musculus; bodyweight 20–30 g) were used for 
animal studies. Before the experiments, the animals were acclimated 
for 1 week with food and water provided ad libitum. This study was 
approved by the Ethics Committee of Faculty of Medicine, Universitas 
Indonesia (No. 232/UN2.F1/ETIK/2017).
Preparation of plant extract
Dried TFG extract was dissolved in a CMC–Na suspension. TFG solutions 
were prepared at three dose levels (308, 616, and 1232 mg/kg) and 
administered orally.
Total flavonoid and phenolic contents
Total flavonoid content was determined from a working solution 
of plant extract. Plant extract (equivalent to 200 mg aqueous 
extract) was added to a round-bottom flask containing 1 mL of 0.5% 
hexamethylenetetramine, 20 mL of acetone, and 2 mL of 25% HCl. 
The suspension was refluxed for 30 min and filtered into a 100 mL 
volumetric flask. Then, 20 mL of filtrate was extracted with ethyl 
acetate 3 times, and the extract was collected and added to 50 mL of 
ethyl acetate in a volumetric flask. To prepare a blank solution, 10 mL of 
working solution was added to glacial acetic acid in a 25-mL volumetric 
flask. To prepare the sample solution, 10 mL of working solution was 
added to 1 mL of 2% AlCl3 and glacial acetic acid in a 25-mL volumetric 
flask.
Total phenolic content was determined using the Folin–Ciocalteu test. 
Absorbance was measured at λ=725 nm.
Animal procedures
The in vivo study had two outcomes: Bleeding duration and survival 
rate. Bleeding duration was determined by the tail-bleeding assay. 
DDY mice were randomly assigned to five groups with five animals 
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per group: Vehicle control, positive control (aspirin), and three 
experimental groups receiving different doses of TFG extract. To assess 
survival rates, DDY mice were randomly assigned to six groups with five 
animals per group: Vehicle control (CMC), positive control (aspirin), 
negative control (CMC), and three experimental groups receiving 
different doses of TFG extract. Treatments were orally administered for 
7 days as indicated in Tables 1 and 2.
Tail-bleeding assay
At 5 h after the last administration of extract on the last day of treatment, 
aspirin, or vehicle alone, animals were anesthetized using ether. A 10-
mm incision was made on the tail from the tip using a surgical blade. The 
end of the incised tail was immediately immersed in the isotonic saline 
solution in a Falcon tube. Each mouse was observed for 20 min to record 
bleeding duration. If the bleeding was not constant, the total duration of 
bleeding within 20 min was summed up. The experiment was stopped 
after 20 min to prevent the death of the experimental animals [2].
Pulmonary thromboembolism model
Survival rates were determined using a slightly modified pulmonary 
thromboembolism model described by Saputri et al. [2]. At 24 h after 
the last treatment administration, experimental animals were injected 
with collagen-epinephrine (700 μg and 42 μg, respectively) in isotonic 
saline solution. The mice were observed for 15 min to assess lethal or 
total thrombosis. A positive control mice were given an injection with 
paralyzing effect. Efficacy in the three groups treated with TFG extract 
was calculated by comparison with the control group. Survival rates 











Total flavonoid and phenolic contents of TFG extract
Both flavonoids and phenols were undetectable in TFG extract. 
Reportedly, TFG contains polyphenols such as apigenin-7-O-glycoside 
(1955.55 ng/mg) and luteolin-7-O-glycoside (725.50 ng/mg) [8]. Little 
flavonoids present in TFG might be difficult to detect.
Bleeding duration
Compared to treatment with vehicle alone, treatment for 7 days with 
TFG extract increased bleeding duration in mice. As shown in Table 3, 
bleeding duration in the positive control and TFG-treated groups was 
significantly different from that in the group treated with vehicle alone 
(p<0.05). The highest mean value of bleeding duration was observed in 
the TFG D3 group (15.99±4.51 min).
Survival rate
Compared with the negative control group, treatment for 7 days with 
TFG extract increased survival rate in mice. As shown in Table 4, the 
highest survival rate was observed in the TFG D3 group (80%).
DISCUSSION
Traditional medicines are essential, especially in developing countries. 
Moreover, plant-derived compounds have played an important key role 
in drug discovery [9]. Therefore, his study aimed to investigate the 
antiplatelet and antithrombotic activities of TFG. Platelet aggregation is 
essential for homeostasis. Antithrombotic agents have been developed 
to mitigate or prevent deregulated thrombosis [10]. Thrombin is the key 
effector enzyme of the coagulation system. The biologically important 
functions include activation of platelets, conversion of fibrinogen to a 
fibrin network, and feedback amplification of coagulation [11].
Bleeding duration
Platelets are essential in the maintenance of cardiovascular integrity and 
in the control of bleeding through forming blood clot [12]. In this study, 
TFG-treated mice showed significantly increased bleeding duration, which 
is in agreement with a previous in vitro study showing that TFG extract 
possessed antithrombotic activity [5]. Increased bleeding duration is due 
to coumarin constituents of TFG seeds that inhibit Vitamin K function, 
resulting in the disruption of prothrombin biosynthesis [6,13].
Survival rate
Survival rates of mice treated with all three doses of TFG extract were 
higher than those of negative controls. The TFG D3 group - administered Table 1: Treatment groups for the tail-bleeding assay
Groups Treatment
Days 1–7 Day 7 (5 h after last 
administration)
Vehicle CMC–Na Tail-bleeding assay
ASA Aspirin
TFG D1 TFG extract
TFG D2
TFG D3
Vehicle (CMC 0.5% volume 0.3 mL/20 g bodyweight), ASA (aspirin 
0.208 mg/20 g bodyweight), TFG D1 (6.16 mg/20 g bodyweight), 
TFG D2 (12.32 mg/20 g bodyweight), and TFG D3 (24.64 mg/20 g bodyweight).
TFG: Trigonella foenum-graceum, ASA: Acetylsalicylic acid, CMC: Carboxymethyl 
cellulose
Table 2: Treatment groups for assessment of survival rates
Groups Treatment
Days 1–7 Day 8
Vehicle CMC–Na Isotonic saline injection
Negative CMC–Na
ASA Aspirin Collagen/epinephrine solution injection
TFG D1 TFG extract
TFG D2
TFG D3
Vehicle (CMC 0.5% volume: 0.3 mL/20 g bodyweight), ASA (aspirin 
0.208 mg/20 g bodyweight), TFG D1 (6.16 mg/20 g bodyweight), TFG 
D2 (12.32 mg/20 g bodyweight), and TFG D3 (24.64 mg/20 g bodyweight). 
TFG: Trigonella foenum-graceum, ASA: Acetylsalicylic acid, CMC: Carboxymethyl 
cellulose
Table 3: Bleeding duration in TFG-treated and control mice







Vehicle (CMC 0.5% volume: 0.3 mL/20 g bodyweight), ASA (aspirin 
0.208 mg/20 g bodyweight), TFG D1 (6.16 mg/20 g bodyweight), TFG 
D2 (12.32 mg/20 g bodyweight), and TFG D3 (24.64 mg/20 g bodyweight). 
*p<0.05 compared to the vehicle control group. SD: Standard deviation, TFG: 
Trigonella foenum-graceum, ASA: Acetylsalicylic acid, CMC: Carboxymethyl 
cellulose
Table 4: Result of survival rate







Vehicle (CMC 0.5% volume: 0.3 mL/20 g bodyweight), ASA (aspirin 
0.208 mg/20 g bodyweight), TFG D1 (6.16 mg/20 g bodyweight), TFG 
D2 (12.32 mg/20 g bodyweight), and TFG D3 (24.64 mg/20 g bodyweight).
TFG: Trigonella foenum-graceum, ASA: Acetylsalicylic acid, CMC: Carboxymethyl 
cellulose
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the highest dose - showed the highest survival rate (80%). Mice treated 
with a higher dose of TFG extract showed higher survival rates, which 
is consistent with a previous study showing that aqueous TFG extract 
inhibited coagulation in a dose-dependent manner [14].
CONCLUSION
The interaction between platelets and blood vessels is important in 
the development of thrombosis and cardiovascular diseases. This 
study showed that TFG has antithrombotic activity in male mice by 
significantly increasing bleeding duration and survival rate. Our results 
confirmed the results of previous in vitro studies. Further studies are 
warranted to determine the specific TFG constituents responsible for 
these effects and their mechanisms of action.
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